| Date | Title | Description |
| 19.09.2024 | A New Dawn in Kidney Cancer Treatment: Roswell Park's Breakthrough Regimen | In the realm of cancer treatment, hope often flickers like a candle in the dark. But recent findings from Roswell Park Comprehensive Cancer Center have ignited a brighter flame for patients battling metastatic kidney cancer. At the European... |
| 19.09.2024 | Радиофармацевтические препараты назвали прорывом в борьбе с раком | Производители лекарств делают ставку на то, что доставка радиации непосредственно к опухолям станет следующим большим прорывом в борьбе с раком. Bristol Myers Squibb, AstraZeneca, Eli Lilly и другие фармацевтические компании потратили около... |
| 18.09.2024 | Tech Park Basel zieht Bilanz |
Der Tech Park Basel ist seit Sommer 2011 in Betrieb. Neben den auf die Nutzung durch junge Technologieunternehmen zugeschnittenen Büro- und Laborflächen stellt der Tech Park Basel auch verschiedene Infrastrukturen bereit und bietet Dienstl... |
| 17.09.2024 | FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer | Ad hoc announcement pursuant to Art. 53 LR
Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant therapy1,2
Kisqali® (ribo... |
| 16.09.2024 | ONL Therapeutics Closes $65M Series D Financing | ONL Therapeutics, an Ann Arbor, MI-based clinical-stage biopharmaceutical company focused on advancing treatments of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD), raised $65M in Series D funding.
The ro... |
| 15.09.2024 | Roswell Park-Designed Treatment Regimen Doubles Progression-Free Survival in Metastatic Kidney Cancer | Roswell Park's Saby George, MD, presented study findings highlighting a treatment combination shown to extend survival in patients with advanced kidney cancer.
During the European Society for Medical Oncology (ESMO) Congress, Saby George, M... |
| 12.09.2024 | The Hidden Struggles of X-Linked Hypophosphatemia: A Call for Awareness and Action | X-linked hypophosphatemia (XLH) is a name that may not ring a bell for many. Yet, for those affected, it’s a daily battle. A recent analysis from the XLH Disease Monitoring Program (DMP) sheds light on the harsh realities faced by adults li... |
| 11.09.2024 | Y Combinator-backed Cerrion raises $5 million in funding to boost AI Video tech in manufacturing | Zurich video AI startup Cerrion has raised $5 million in funding.
The round was led by Y Combinator and Justin Kan’s Goat Capital, with additional participation from session.vc, Soma Capital, 10x Founders, Rebel Fund and renowned angel inve... |
| 10.09.2024 | Cerrion: The Dawn of AI in Manufacturing Automation | In the world of manufacturing, time is money. Every second lost to inefficiency can cost companies dearly. Enter Cerrion, a Zurich-based start-up that is reshaping the landscape of industrial automation. With a fresh infusion of $5 million ... |
| 10.09.2024 | Epsilogen Secures £12.5 Million to Propel Cancer Treatment Innovations | Epsilogen, a pioneering force in the realm of immunoglobulin E (IgE) antibodies, has successfully raised £12.5 million in a Series B funding round. This brings the total Series B financing to an impressive £43.25 million. The funds will be ... |
| 10.09.2024 | AI-powered automation start-up Cerrion raises USD 5 million |
By automating tasks traditionally handled by skilled operators, Cerrion’s AI video-led technology helps manufacturers maintain productivity despite workforce shortages. It leverages standard CCTV cameras to learn and monitor production pro... |
| 10.09.2024 | Great Lakes Institute of Management, Gurgaon, Conducts its 13th Annual Convocation | Delhi, India
Great Lakes Institute of Management, Gurgaon conducted its 13th Annual Convocation on 24th August 2024 at the Manekshaw Centre Auditorium, New Delhi. A total of 342 students successfully graduated on this day from two programs:... |
| 09.09.2024 | More space for healthtech start-ups on the Novartis Campus |
Digitalisation is one of the megatrends in the healthcare sector. It not only promises greater efficiency, but also new possibilities in diagnostics and therapeutics. As this field requires expertise that traditional healthcare companies o... |
| 09.09.2024 | Epsilogen: Immunoglobulin Development Company Raises £12.5 Million (Series B) | Epsilogen – a leader in the development of immunoglobulin E (IgE) antibodies to treat cancer – announced today the completion of a £12.5 million Series B expansion financing, bringing the Series B total to £43.25 million. The funding will a... |
| 05.09.2024 | Novartis Expands Radioligand Therapy Manufacturing in the U.S. | In a bold move to combat cancer, Novartis is laying the groundwork for two new radioligand therapy (RLT) manufacturing facilities in the United States. This expansion is not just a step; it’s a leap into the future of cancer treatment. With... |
| 05.09.2024 | Raising Awareness and Empowering Patients: The Fight Against Kidney Disease | Kidney disease is a silent predator. It lurks in the shadows, often unnoticed until it strikes. The statistics are alarming. Approximately 35.5 million adults in the U.S. have chronic kidney disease (CKD), yet around 90% are unaware of thei... |
| 04.09.2024 | Ian Michael Crumm to emcee the 2024 New York Miles for Melanoma 5K | Ian Michael Crumm, 2024 New York Miles for Melanoma 5K event emcee
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patien... |
| 04.09.2024 | Novartis begins construction of two new radioligand therapy facilities in the US, expanding its world-class RLT manufacturing and supply network | Indianapolis site expansion will establish in-house production of isotopes critical for production of radioligand therapies (RLTs) for cancer treatment
New facility in California will be third US-based RLT production facility
Novartis is ex... |
| 04.09.2024 | The NKF Launches New Online Educational Tool for People Living with Chronic Kidney Disease | ~NKF Patient Journey: Chronic Kidney Disease Offers An Individualized Educational Curriculum~
NEW YORK, Sept. 4, 2024 /PRNewswire/ -- Today, the National Kidney Foundation (NKF) launched NKF Patient Journey: Chronic Kidney Disease, a new in... |
| 03.09.2024 | Parkinson’s Disease Drug Market: Trends, Growth, and Segmentation | Share
Tweet
Share
Share
Email
Parkinson’s disease, a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, affects millions of individuals worldwide. As the global population age... |
| 03.09.2024 | SKIES ACROSS NORTH AMERICA TO LIGHT UP THIS FALL IN SUPPORT OF BLOOD CANCER PATIENTS | The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support is critical
RYE BROOK, N.Y., Sept. 3, 2024 /PRNewswire/ -- The Leukemia & Lymphom... |
| 03.09.2024 | Pharmaceutical Market: Trends, Segmentation, and Growth Opportunities | Share
Tweet
Share
Share
Email
In recent years, the pharmaceutical market has witnessed remarkable growth and transformation, driven by technological advancements, evolving consumer needs, and the global push for better healthcare solutions.... |
| 03.09.2024 | General Anesthesia Drugs Market: Trends, Segmentation, and Future Outlook | Share
Tweet
Share
Share
Email
The global general anesthesia drugs market has been experiencing significant evolution, driven by advancements in medical technology, increasing surgical procedures, and a growing emphasis on patient safety and... |
| 03.09.2024 | NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024 | PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- NephCure, a leading nonprofit organization dedicated to finding better treatments and a cure for rare kidney disease, is proud to announce the inaugural IgA Nephropathy (IgAN) Awareness Day on Sep... |
| 29.08.2024 | Navigating the New Normal: COVID Vaccines and Creative Leadership in Healthcare | The landscape of healthcare marketing is shifting. Imre, a prominent brand engagement agency, has made significant strides by appointing Tracy Zuto and Malia Baker as key creative leaders. Their arrival signals a commitment to innovative, i... |
| 28.08.2024 | Imre announced two new appointments to Strengthen Brand AOR Expertise | Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of two senior creative leaders, as the agency strengthens its position as a distinct choice for agency-of-record assignments in healthc... |
| 27.08.2024 | Imre Appoints Powerhouse Leaders Tracy Zuto and Malia Baker and Strengthens Brand AOR Expertise | New Additions Reflect Commitment to Creative Excellence and Healthcare Industry Leadership
NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Imre continues its commitment to cutting-edge creative that builds brand engagement with the appointment of t... |
| 26.08.2024 | Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain Inhibitor | Appoints Axel Bolte, MBA, MSc, to Board Director and Stephanie Oestreich, PhD, MPA, to Board Observer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–August 26, 2024–
Opna Bio announced that it has dosed the first patient with OPN-6602, a poten... |
| 24.08.2024 | The Rise of RNA Medicines: Borealis Biosciences and the Future of Kidney Disease Treatment | In the world of biotechnology, innovation is the lifeblood. Borealis Biosciences has emerged as a beacon of hope in the treatment of kidney diseases. Recently, the company raised $150 million in Series A financing, marking a significant mil... |
| 22.08.2024 | Global Genes' Annual Week in RARE Event Heading to Kansas City | Global Genes
Global Genes is taking Week In RARE on the road to Kansas City, after having hosted this annual event in California for over 12 years. Moving the location annually will help make the event more accessible and equitable to the g... |
| 22.08.2024 | Borealis Biosciences: RNA Medicines Company Raises $150 Million (Series A) | Borealis Biosciences, a next-generation RNA medicines company, has emerged from stealth with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis, and committed strategic research collaboration fu... |
| 22.08.2024 | Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M | Novartis’ $3.2 billion deal for Chinook Therapeutics gave the Swiss Big Pharma such a taste for kidney disease-focused biotechs that it has partnered with VC firm Versant Ventures to create another company in a similar mold.
Borealis Biosci... |
| 22.08.2024 | Trinity Life Sciences Announces New Customer Engagement Solutions | Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new ... |
| 21.08.2024 | Glenmark and SalioGen: A New Era in Ophthalmic Treatments | In the bustling world of pharmaceuticals and biotechnology, two companies are making waves in the ophthalmic sector. Glenmark Therapeutics Inc. and SalioGen Therapeutics are not just players; they are pioneers. Their recent announcements re... |
| 21.08.2024 | Innovations in Financial Planning: A New Era for Later Life Management | In the world of finance, innovation is the lifeblood that keeps the industry vibrant. Recently, two companies emerged as champions in the Later Life Financial Planning Innovation Challenge, hosted by Smart Data Foundry and FinTech Scotland.... |
| 20.08.2024 | REPUBLICA HAVAS EXPANDS NORTH AMERICAN FOOTPRINT WITH THREE APPOINTMENTS | A trio of executives has been appointed to lead the agency's expansion into New York City
NEW YORK, Aug. 20, 2024 /PRNewswire/ - Republica Havas announced today the appointments of three executives to lead the agency's continued expansion i... |
| 19.08.2024 | Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC) | MAHWAH, N.J., Aug. 19, 2024 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce it has launched1 Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC); compare to the active ingredient in Pataday®2 Twic... |
| 19.08.2024 | SalioGen Therapeutics Appoints Kali Stasi, M.D., Ph.D. as Chief Medical Officer | -Dr. Stasi brings to SalioGen 30 years of experience in ophthalmology and genetic medicine-
LEXINGTON, Mass., Aug. 19, 2024 /PRNewswire/ -- SalioGen Therapeutics, a biotechnology company developing next-generation genetic medicines based on... |
| 17.08.2024 | KNIME: Open-Source Data Science And AI Company Raises $30 Million | KNIME, one of the leading open-source data science and AI companies, announced it has raised additional funding from its longstanding investor, Invus. Since the last announcement, Invus has invested another $30 million, bringing the total f... |
| 15.08.2024 | Invus invests additional $30M in Knime |
KNIME helps everybody make sense of data. Its free and open-source KNIME Analytics Platform enables anyone – from business to technical and data backgrounds – to intuitively work with data. KNIME Hub is the commercial complement to KNIME A... |
| 09.08.2024 | GenScript Biotech Reports First Half 2024 Results | Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development
Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy rev... |
| 08.08.2024 | Novartis Pharma K.K. Novartis achieved significant sales growth and improved core operating profit margin in the second quarter; upwardly revised full-year 2024 core operating profit forecast | - |
| 08.08.2024 | Gilead quarterly profit beats Street estimates, revenue up 5% | Healthcare & PharmaceuticalsCommercial Strategy
Gilead quarterly profit beats Street estimates, revenue up 5%
By Deena BeasleyAugust 8, 20248:05 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Li... |
| 08.08.2024 | Novartis Pharma K.K. Novartis achieved significant sales growth and improved core operating profit margin in the second quarter; upwardly revised full-year 2024 core operating profit forecast | Novartis Pharma K.K.
Novartis achieved strong sales growth and improved core operating profit margin in the second quarter; revised full-year 2024 core operating profit forecast upward
……
This material is a Japanese translation (summary) of... |
| 07.08.2024 | KNIME's Bold Leap into the Future of AI Governance | In the fast-paced world of artificial intelligence, the race is on. Companies are scrambling to harness the power of AI while managing its risks. KNIME, a leader in open-source data science, has just made a significant move. The company sec... |
| 07.08.2024 | Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN) | Ad hoc announcement pursuant to Art. 53 LR
Fabhalta achieved a 44% proteinuria reduction from baseline in Phase III APPLAUSE-IgAN interim analysis, compared with 9% in placebo arm, demonstrating a clinically meaningful reduction of 38% vs. ... |
| 07.08.2024 | Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN) | Fabhalta achieved a 44% proteinuria reduction from baseline in Phase III APPLAUSE-IgAN interim analysis, compared with 9% in placebo arm, demonstrating a clinically meaningful reduction of 38% vs. placebo (p |
| 06.08.2024 | Open-source data science platform Knime raises $30M to seize opportunity in generative AI
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mi... | Open-source data science platform provider Knime AG said today it has closed on a new, $30 million investment from its longtime backer Invus.
The round is the first major investment the company has received since Invus led its initial Serie... |
| 06.08.2024 | KNIME Secures Investment to Accelerate Enterprise AI Governance and ModelOps | KNIME, one of the leading open-source data science and AI companies, has raised additional funding from its longstanding investor Invus. Since the last announcement, Invus invested another $30M, bringing total funding to $50M. This will all... |
| 05.08.2024 | QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER | Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Ph... |
| 05.08.2024 | QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER | Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Ph... |
| 01.08.2024 | Shanghai to ramp up support for cutting-edge biomedical tech | Lujiazui, the financial center in Shanghai, forms a perfect backdrop to the Bund area. [Wang Gang/For China Daily]
Shanghai will strengthen efforts to develop cutting-edge biomedical technologies, such as gene and cell therapies, mRNA, synt... |
| 27.07.2024 | The Shifting Landscape of Biopharma and Real Estate in Colorado | In the heart of Colorado, two significant developments are reshaping the landscape of biopharmaceuticals and commercial real estate. The recent acquisition of a former Mile High Labs site by ScanlanKemperBard (SKB) and a strategic collabora... |
| 27.07.2024 | The Future of Brain Health: Innovations and Leadership in Alzheimer's and Multiple Sclerosis Treatments | In the ever-evolving landscape of biotechnology, two companies are making waves in the treatment of chronic neurological diseases: Immunic, Inc. and Neurophet. Both are leveraging advanced technologies and seasoned leadership to tackle the ... |
| 25.07.2024 | A Race Against Melanoma: Cleveland's Miles for Melanoma 5K**
** | ** On a sunny August morning, the air buzzes with anticipation. The Cleveland Miles for Melanoma 5K is set to unfold at Edgewater Park. This event is more than just a race; it’s a lifeline. It brings together a community united by a common ... |
| 25.07.2024 | The Rising Tide of Myopia: A Call to Action for Parents and Communities**
** | ** In a world increasingly dominated by screens, the vision of our children hangs in the balance. Myopia, or nearsightedness, is not just a minor inconvenience; it’s a growing epidemic. The statistics are staggering. In Singapore, 65% of ch... |
| 24.07.2024 | Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec | – Senior Executive and Thought Leader in Brain Health with Nearly Three Decades of Global Pharmaceutical Experience –
– Served as Neuroimmunology Franchise Head Responsible for Roche's Blockbuster Launch of Multiple Sclerosis Therapy Ocrevu... |
| 24.07.2024 | Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer | – Collaboration combines Dren’s targeted cell depletion platform with Novartis research, development and commercial expertise to advance innovative therapies for cancer –
– Dren Bio to receive total upfront consideration of $150 million and... |
| 24.07.2024 | Business | ScanlanKemperBard buys former Sandoz, Mile High Labs site in Broomfield | Novartis cited double-digit price erosion from consolidation and increased competition in the U.S. generic drug market as reasons for the closure.
Originally based in Longmont when it was founded in 2016, Mile High Labs moved production to ... |
| 19.07.2024 | The Melanoma Research Foundation to host the Cleveland Miles for Melanoma 5K | Apex Skin
The Melanoma Research Foundation (MRF) is thrilled to announce one of the next events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This ... |
| 18.07.2024 | Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance | Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+28% cc), Kesimpta (+65% cc), Cosentyx (+22... |
| 10.07.2024 | Azzur Group Appoints Two New Laboratory Directors | HATBORO, Pa., July 10, 2024 /PRNewswire/ -- Azzur Group today announces the appointment of new leadership for its cGMP microbiology and analytical laboratories. Joy Ghosh, PhD, has been named Senior Director, Laboratory Services in Schnecks... |
| 09.07.2024 | The 5G Revolution: Transforming Healthcare and Smartphone Markets | A deep dive into the impact of 5G technology on healthcare services and smartphone markets, highlighting the growth of MediaTek in the 5G smartphone sector and the potential of 5G in revolutionizing patient care and remote medicine.
5G Tech... |
| 08.07.2024 | BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial | SHANGHAI, July 8, 2024 /PRNewswire/ -- BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in the 2-SUCCEED trial: a randomized, double-bli... |
| 07.07.2024 | Hainan Free Trade Port deepens cooperation with Switzerland | HAIKOU, China, July 7, 2024 /PRNewswire/ -- A report from Hainan International Media Center (HIMC):
On July 4, the Hainan Free Trade Port Medical & Health Industry Exchange Meeting was held in Zurich, Switzerland.
From July 4-6, a deleg... |
| 06.07.2024 | 5G Technology: Revolutionizing Healthcare and Remote Medicine | Share
Tweet
Share
Share
Email
The advent of 5G technology marks a new era in the field of telecommunications. While its potential is vast across various sectors, one of the most transformative impacts of 5G is seen in healthcare and remote ... |
| 01.07.2024 | Inaugural European entrepreneur award crowns HAYA Therapeutics Founders |
Recognizing entrepreneurial vision and talent in the life sciences among the DACH region, which includes Germany, Austria and Switzerland, the award honors the efforts of Drs. Ounzain and Blessing in creating a company developing an innova... |
| 28.06.2024 | PepTalkHer Buys Mettacool | Mettacool Co-CEOs Molly Dewey (L) and Natalie Eicher (R) with Meggie Palmer, CEO and Co-Founder, PepTalkHer (Center)
PepTalkHer, an executive coaching platform and app dedicated to fostering professional growth and equitable pay, acquired l... |
| 21.06.2024 | Envision Energy's Path to Net Zero: A Green Revolution Unveiled | Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich, showcasing its remarkable achievements in global decarbonization. This report marks the company's second consecutive... |
| 21.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 21, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report at Intersolar in Munich. This report highlights the company's ongoing decarbonization achievements, mar... |
| 20.06.2024 | Envision Energy Releases 2024 Net Zero Action Report Highlighting Global Decarbonization Achievements | MUNICH, June 20, 2024 /PRNewswire/ -- Envision Energy, a global leader in green technology, has unveiled its 2024 Net Zero Action Report in Intersolar, declaring its second consecutive year of carbon-neutral operations on a global scale. Th... |
| 19.06.2024 | CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A | ATLANTA, June 19, 2024 /PRNewswire/ -- The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has formed a strategic partnership with ReviR Therapeutics to advance... |
| 18.06.2024 | Выдающийся врач-онколог Павел Борисович Попов: от детских экспериментов до мировой славы | - |
| 18.06.2024 | Axtria Announces its First Ignite Leadership Award Honorees | Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry
BERKELEY HEIGHTS, N.J., June 18, 2024 /PRNewswire/ -- Axtria, a global leader in cloud software and data analytics for the life sciences industry, has a... |
| 18.06.2024 | Learn To Win: Enterprise SaaS Training Company Raises $30 Million | Learn to Win, a leading provider of personalized, predictive, and secure enterprise training software, announced it has raised an oversubscribed $30 million in Series A funding led by the Westly Group, with follow-on participation from Norw... |
| 11.06.2024 | QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors | Industry veteran Williamson brings nearly three decades' experience as a leader in neuroscience R&D at organizations including Eli Lilly and Company, Lundbeck, Parexel, and Acadia Pharmaceuticals
Former Karuna CFO Brown brings more than... |
| 08.06.2024 | Three-year AI-focused programme MOU signed by Egypt’s ITIDA, Techne | With an eye toward revolutionizing the artificial intelligence (AI) landscape throughout Africa, particularly in Egypt, the Information Technology Industry Development Agency (ITIDA) of Egypt has teamed up with Techne Summit.
A Memorandum o... |
| 07.06.2024 | «Мы должны иметь возможность в любой момент развернуть производство востребованных лекарств» | - |
| 30.05.2024 | Merck заплатит $3 млрд за стартап по лечению глаз Eyebiotech | Согласно заявлению, сделанному в среду, Merck заплатит $1,3 млрд авансом и еще $1,7 млрд, если британская компания достигнет будущих бизнес-целей. Ведущим активом EyeBio является Restoret, экспериментальное антитело ранней стадии, предназна... |
| 30.05.2024 | US, UK in focus as pharma companies eye $31 billion exports in FY25 | - |
| 29.05.2024 | «Фармпроизводителям искусственно ограничивают доходность» | - |
| 27.05.2024 | Drugmakers to see FY25 revenue boost in key US market: India Ratings | - |
| 25.05.2024 | Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio | In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 week... |
| 24.05.2024 | Kyle Speller to return as Emcee for the 2024 Denver Miles for Melanoma 5K! | Kyle Speller, 2024 Denver Miles for Melanoma 5K event emcee
The Melanoma Research Foundation (MRF) is thrilled to announce that Kyle Speller will be returning to emcee the annual Miles for Melanoma Denver 5K event on Saturday, June 8, 2024 ... |
| 23.05.2024 | Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer | SHANGHAI and WARREN, N.J., May 23, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food and Drugs Administration for the pro... |
| 22.05.2024 | Carbon Biosciences Announces New Appointments to Board of Directors and Scientific Advisory Board | - Carol Ann Satler, MD, PhD, FACC, FAHA, FAAP joins the Board of Directors, adding key clinical experience to guide ongoing nonclinical development in cardiac and pulmonary diseases -
- Lloyd Klickstein, MD, PhD joins the Scientific Advisor... |
| 22.05.2024 | Швейцарская мирная преференция | - |
| 22.05.2024 | Healthcare sector most violative of advertisement rules, says Asci report | - |
| 21.05.2024 | Dermatology segment in IPM poised for 11- 12% growth amid rising demand | - |
| 20.05.2024 | Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs | - |
| 15.05.2024 | Chinese biotech crackdown would reset U.S. drug development | figcaption>span]:font-sans">
Lawmakers in the House of Representatives on Wednesday are expected to set in motion a massive reordering of how U.S. pharmaceuticals are developed and made, by advancing a contracting ban on five key... |
| 14.05.2024 | The National Kidney Foundation's 2024 Spring Clinical Meetings Late-Breaking Presentation on New Therapy Shows Promising Results for IgAN Patients | NEW YORK, May 14, 2024 /PRNewswire/ -- During a late-breaking abstract presentation at the annual 2024 NKF Spring Clinical Meetings (SCM) tomorrow Dr. Dana Rizk, from the University of Alabama at Birmingham (UAB) Medical Center, will presen... |
| 10.05.2024 | A strong start for Axmed |
Despite representing over 80% of the world's population, low- and middle-income countries (LMICs) account for a mere 6% of global pharmaceutical revenue, yet they represent a burgeoning $140 billion sector, with Africa alone accounting for... |
| 08.05.2024 | Global Heart Hub's real-life data highlights need for patient-centered management of unhealthy cholesterol | First findings from multi-national patient research underpin the importance of integrating patient needs and preferences into strategies for managing unhealthy cholesterol
First of its kind, community-led research by Global Heart Hub suppor... |
| 07.05.2024 | Prevent Blindness to Host the 2024 ASPECT Patient Engagement and Advocacy Summit in Washington, D.C. | Prevent Blindness to host the 2024 ASPECT Patient Engagement and Advocacy Summit and Eyes on Capitol Hill event in Washington, D.C., May 14-16, 2024.
Three-day event brings together patients, care partners, and public health champions to ad... |
| 04.05.2024 | Илон Маск бьет своих и дружит с китайцами, а японцы скрывают стратегические разработки: дайджест новостей | Массовые увольнения под новую стратегию Tesla, истребление фальшивых фармпатентов, очередные достижения Китая в ИИ. О главном за неделю в мире интеллектуальной собственности — в нашем дайджесте.
Кадровая резня имени Маска: всё ради фокуса н... |
| 03.05.2024 | Novartis купит американскую радиофармацевтическую компанию Mariana Oncology за $1 млрд | Mariana Oncology работает над новыми методами лечения рака радиолигандами (RLT), которые еще не были протестированы на людях.
«Сделка укрепляет портфель Novartis RLT и расширяет исследовательскую инфраструктуру компании и возможности клинич... |
| 03.05.2024 | Dr Reddy's Laboratories launches generic anti-bacterial medication in US | - |
| 03.05.2024 | Patients on hunt for diabetes, obesity and weight-loss drugs | - |
| 03.05.2024 | Airbus called for compensation to take on money-losing Spirit operations, sources say | DealsAirbus called for compensation to take on money-losing Spirit operations, sources say
By Allison Lampert and Mike StoneMay 2, 202411:01 PM UTCUpdated ago
Save
Text
Small Text
Medium Text
Large Text
Share
Twitter
Facebook
Linkedin
Email... |
